https://clinicaltrials.gov/study/NCT03967600
Clinical Trial Location: United States
Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation
https://clinicaltrials.gov/study/NCT06517732
Deucravacitinib Clinical Trial
https://clinicaltrials.gov/study/NCT05997277
Botulinum Toxin Therapy in Hidradenitis Suppurativa
https://clinicaltrials.gov/study/NCT05403710
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
https://clinicaltrials.gov/study/NCT05889182
A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/study/NCT06046729
A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/study/NCT06028230
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
https://clinicaltrials.gov/study/NCT05635266
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.
https://clinicaltrials.gov/study/NCT05921994
Patient’s Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation
https://clinicaltrials.gov/study/NCT06444087
Physical Activity Trial
https://clinicaltrials.gov/study/NCT06015438
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
https://clinicaltrials.gov/study/NCT04218422